Drug Side Effects
Search
ECZEMA IMPETIGINOUS
ECZEMA IMPETIGINOUS
was reported 43 times
ECZEMA IMPETIGINOUS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Interleukin-5 Antagonist [EPC]
1
0.0015
1
Epidermal Growth Factor Receptor Antagonist [EPC]
6
0.0001
2
Interleukin-17A Antagonist [EPC]
3
0.0001
3
RNA Synthetase Inhibitor Antibacterial [EPC]
1
0.0001
4
Leukotriene Receptor Antagonist [EPC]
1
0.0000
5
Provitamin D2 Compound [EPC]
1
0.0000
6
Tetracycline-class Drug [EPC]
2
0.0000
7
Vascular Endothelial Growth Factor Inhibitor [EPC]
5
0.0000
8
Platinum-based Drug [EPC]
6
0.0000
9
Nucleoside Metabolic Inhibitor [EPC]
5
0.0000
10
Fluoroquinolone Antibacterial [EPC]
2
0.0000
11
Arteriolar Vasodilator [EPC]
1
0.0000
12
Histamine-1 Receptor Antagonist [EPC]
1
0.0000
13
Nucleoside Analog Antiviral [EPC]
1
0.0000
14
5-alpha Reductase Inhibitor [EPC]
1
0.0000
15
Interleukin-23 Antagonist [EPC]
1
0.0000
16
Leukocyte Growth Factor [EPC]
1
0.0000
17
Proton Pump Inhibitor [EPC]
4
0.0000
18
Folate Analog Metabolic Inhibitor [EPC]
3
0.0000
19
Angiotensin 2 Receptor Blocker [EPC]
2
0.0000
20
Phosphodiesterase 4 Inhibitor [EPC]
1
0.0000
21
Corticosteroid [EPC]
7
0.0000
22
RANK Ligand Inhibitor [EPC]
1
0.0000
23
Tumor Necrosis Factor Blocker [EPC]
1
0.0000